Comment on "Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies" and "High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints".

Kong, Leping; Alffenaar, Jan-Willem C; Stocker, Sophie L

Kong, Leping; Alffenaar, Jan-Willem C; Stocker, Sophie L.

Afiliação

Kong L; Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.
Alffenaar JC; Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, NSW, Australia.
Stocker SL; The University of Sydney Infectious Disease Institute, Sydney, NSW, Australia.

Clin Pharmacokinet ; 63(5): 731-733, 2024 May.

Article em En | MEDLINE | ID: mdl-38573478

Assuntos

Antifúngicos; Estado Terminal; Nitrilas; Piridinas; Triazóis; Humanos; Piridinas/farmacocinética; Piridinas/administração & dosagem; Nitrilas/farmacocinética; Nitrilas/administração & dosagem; Nitrilas/farmacologia; Triazóis/farmacocinética; Triazóis/administração & dosagem; Triazóis/farmacologia; Antifúngicos/farmacocinética; Antifúngicos/administração & dosagem; Antifúngicos/farmacologia; Relação Dose-Resposta a Droga

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Triazóis / Estado Terminal / Antifúngicos / Nitrilas Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google